The Spanish Life Sciences Web Portal
This is a free web portal for the life sciences in Spain and Portugal... » read more
- Neovacs: Production Partnership with 3P Biopharmaceuticals (2016-11-23)
Agreement addresses future production needs of IFNa, key component of IFN Kinoid1 Neovacs (Alternext Paris: ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced a partnership with 3P Biopharmaceuticals, a leader ...
- Sygnis AG Reports Nine Month Results for 2016 (2016-11-09)
> Revenues increased over 300% - increased kit sales and sales from proteomics business > EBIT improved by 22% > Integration of Expedeon on track and proceeding well SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today reported results f...
- CorWave Raises $17.1m in Series B Financing (2016-11-04)
CorWave, a medical technology company that develops innovative mechanical circulatory support devices, has announced that it has completed a $17.1 million (€15.5M) Series B financing. Existing shareholders including Sofinnova Partners, Bpifrance and Seventure were ...
- PharmaMar Group Reports 9M 2016 Financial Results (2016-10-27)
> PharmaMar Group reports €131.1 million in net sales (+4.7%) > Commercial sales of Yondelis®, net of raw material sales, increased by 9.7%. > Consumer Chemicals net sales increased by 6.7% to €59.2 million. Grupo Pharma Mar (PHM.MC) today announced its ...
- Sygnis AG: €1.9m Non-dilutive R&D Funding from Spanish Govt (2016-10-27)
Public soft loans of €1.2 million and grants of € 0.75 million to fund R&D collaboration of SYGNIS AG with the Spanish National Center for Molecular Biology, San Carlos Hospital and the R&D foundation Juan Dominguez SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM...
- OncoDNA to Provide Tumor Profiling Services to SOLTI (2016-10-26)
AGATA Aims to Link Patients to Clinical Studies with Targeted Drugs Based on their Individual Tumors Belgium-based OncoDNA SA, The Cancer Theranostic Company, which supplies the only comprehensive solution from cancer profiling (OncoDEEP&TRACE), combining soli...
- PharmaMar Opens New Affiliate in Austria (2016-10-24)
PharmaMar (MSE:PHM) has announced today the opening of a new affiliate in Austria with the aim of reinforcing the presence of the Company within Europe, one of the world's leading oncology markets. As Luis Mora, Managing Director at PharmaMar´s Oncology Business...
- Protagen: Georg Lautscham to Follow Stefan Müllner as CEO (2016-10-18)
Protagen AG. a leading provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today announced changes to their Management Board. Dr. Georg Lautscham will join the company's ...
- Ysios Capital Raises €126,4m for Ysios Biofund II Innvierte (2016-10-18)
– Ysios Capital has closed its second fund, Ysios BioFund II Innvierte, at €126,4 M exceeding its initial target fund size of €100 M. – Ysios BioFund II Innvierte institutional investors include: CDTI (Spanish Ministry of Economy) through its Innvierte program...
- PharmaMar Licenses Aplidin in Korea to Boryung Pharm (2016-10-04)
PharmaMar (MSE:PHM) has announced today a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in South Korea. Under the terms of the agreement, PharmaMar will receive an upfront payment along with royalt...
Life-Sciences-Spain.com is your doorway to the Iberian life sciences!
[LSES] provides free, up-to-date and structured access to
in Spain and Portugal.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSES] is 100% Made in Germany!Start here with the latest News!
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)